Kuznetsov GP, Lebedev PA.
The clinical significance of selenium deficiency in patients from the Samara region with cardiovascular diseases and its correction with the preparation Selena. Eksp Klin Farmakol 1995; 58:26-28.
2. Hassanzadeh M, Faridhosseini R,Mahini M, Faridhosseini F, Ranjbar A. Serum Levels of TNF-Alpha, IL-6, and Selenium in Patients with Acute and Chronic Coronary Artery Disease. Iran J Immunol.3:142-145 ;2006 .
3. Shabestari MM, Jabbari F, Gohari B, Moazen N, Azizi H, Moghiman T, Ibrahimzadeh S, Amirabadi A. Coronary artery angiographic changes in veterans poisoned by mustard gas. Cardiology 2011; 119:208-213.
4. Farid R, Parizadeh MJ, Ghaffari J, Miri S, Nasirian A, Rafatpanah H. Seroepidemiologic study of HTLV-I in Neyshabour. Mashhad Med Faculty J 1383; 83:417-424
5. Rafatpanah H, Pravica V, Faridhosseini R, Tabatabaei A, llier W, Poulton K, Thomson W, Hutchinson I. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection. Iran J Immunol 2007; 4:94-100.
6. Rafatpanah H, Pravica V, Farid R, Abbaszadegan MR, Tabatabaei A, Goharjoo A,
et al.
Association of a novel single nucleotide polymorphism in the human perforin geno with the outcome of HTLV-I infection in patients from northeast Iran (Mashhad). Hum Immunol 2004; 65:839-846 .
7. Farid R, Pishnamaz R. HTLV-I infection and accompanying diseases. Mashhad Med Faculty J 1381; 76:129-140.
8. Fukushima N, Nishiura Y, Nakamura T, Kohno S, Eguchi K. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Int ED 2007; 46:347-351.
9. Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Taylor GP, Weber JN, Bangham CR. High circulating frequencies of tumor necrosis factor alpha-and interleukin-2-secreting human T-lymphotropic virus type 1(HTLV-I)-Specific CD4+ T cells in patients with HTLV-I Associated neurological disease. J Virol 2003 ; 77:9716-9722.
10. Best I, Adaui V, Verdonck K, Gonzalez E, Tipismana M, Clark D, Gutuzzo E, Vanham G. Proviral load and immune markers associated with human T-Lymphotropic virus type 1 (HTLV-I)- associated myelopathy/tropical spastic paraparesis (HAM/TSP) in peru. Clin Exp Immunol 2006; 146:226-233.
11. Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhaes E, Melo A,
et al
. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004; 4:7.
12. Gabarre J, Gessain A, Raphael M, Merle-Béral H, Dubourg O, Fourcade C,
et al.
Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lymphomatous involvement in an Iranian woman: clinical, immunopathological and viromolecular studies, Leukemia 1993 ; 7:1904-1909.
13. Daisley H, Charles W. Cardiac involvement with lymphoma/leukemia: a report of three autopsy cases. Leukemia 1997; 11:522-524.
14. A Hamaad, R C Davis, and D L Connolly. Regression of HTLV-I associated intracardiac lymphoma following chemotherapy. Heart 2002; 88:621.
15. Kumamoto H, Ichinohasama R, Sawai T, Naganuma H, Furukawa Y, Akiu N,
et al
. Multiple organ failure associated with extensive metastatic calcification in a patient with an intermediate state of human T lymphotropic virus type I (HTLV-I) infection: report of an autopsy case. Pathol Int 1998; 48:313-318.
16. O’Mahony D, Debnath I, Janik J, Aisner D, Jaffe E, Waldmann T,
et al
. Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience. Leuk Lymphoma 2008 ; 49:439-446.
17. Iemura A, Yano H, Kojiro M, Nouno R, Kouno K. Massive cardiac involvement of adult T-cell leukemia/lymphoma. An autopsy case. Arch Pathol Lab Med 1991; 115:1052-1054.
18. Thiam M, Dangou JM, Poplin S, Klotz F, Perret JL. Cardiac T cell lymphoma: a case report. Dakar Med 2001; 46:71-72.
19. Stuver SO, Tachibana N, Okayama A, Mueller NE. Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki. Japan J Infect Dis 1996; 173:584-591.
)